Clinical Trials on 晚期 EGFR 阳性实体瘤 in United States
总计3610个结果
-
Changchun Intellicrown Pharmaceutical Co. LTDCovance招聘中
-
Incyte Corporation终止
-
Bliss Biopharmaceutical (Hangzhou) Co., Ltd主动,不招人
-
Turning Point Therapeutics, Inc.终止
-
Aadi Bioscience, Inc.招聘中
-
Turning Point Therapeutics, Inc.招聘中
-
Turning Point Therapeutics, Inc.撤销
-
Zhuhai Yufan Biotechnologies Co., Ltd招聘中
-
Jazz PharmaceuticalsMerck Sharp & Dohme LLC招聘中
-
Novartis Pharmaceuticals招聘中
-
Neurogene Inc.Merck Sharp & Dohme LLC主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | KRAS基因突变 | 转移性恶性实体瘤 | 表皮生长因子受体基因突变 | ERBB2基因扩增 | ERBB2基因突变 | EGFR基因扩增 | ERBB3基因突变 | ERBB4基因突变美国
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
Hoffmann-La Roche完全的
-
Daiichi Sankyo Co., Ltd.招聘中
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.完全的
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Fordham University完全的
-
Avera McKennan Hospital & University Health Center主动,不招人
-
1ST Biotherapeutics, Inc.Merck Sharp & Dohme LLC招聘中